USPatentGranted
S1

Intraocular lens

Granted 27 Jun 2017 · no office action yet

Assignee: Santen Pharmaceutical Co., Ltd.

Law firm: Law firm · Log in to unlock

Attorney: Attorney · Log in to unlock

Inventors: Daniel Hamilton, Jensen Buck, Anand Doraiswamy · Examiner: Charles Hanson · AU 2918 · TC 2900

Application
29/523,190
filed 7 Apr 2015
Publication
Not published
not published
Patent· this page
US D790707
granted 27 Jun 2017

Life of the patent

2 dated events
⤢ drag to zoomApr 2015Jul 2015Oct 2015Jan 2016Apr 2016Jul 2016Oct 2016Jan 2017Apr 2017Jul 2017Prosecution
Prosecutionhover for detail · click to open

Description

1 parts
›FIG. 1 is a front view of an…

FIG. 1 is a front view of an intraocular lens, showing our new design;

FIG. 2 is a rear view thereof;

FIG. 3 is a left side view thereof;

FIG. 4 is a right side view thereof;

FIG. 5 is a top plan view thereof;

FIG. 6 is a bottom view thereof;

FIG. 7 is a perspective view thereof; and,

FIG. 8 is an enlarged sectional view thereof taken on line 8 - 8 of FIG. 1 .

the grant prints no section headings; every part label below is ours, taken from that part's own first words

Claims

1 · 1 independent · depth 1
1 granted claims

Classifications

1 codes
USPC · US Patent Classification
D24/157

Claim changes

Soon
Coming soonHow the claims changed between publication and grant

See which claims were amended, added or cancelled during examination, with every added and removed word marked.

AmendedAddedCancelledUnchanged

The published claims of this patent are not paired with the granted ones in what we hold.

File wrapper

Pendency
2.2 y
812 days filing → grant
Office actions
0
after a restriction
Examiner
Charles Hanson
art unit 2918 · TC 2900
Citations: 19 back · 0 forward

See the full prosecution history — every USPTO and applicant action on this file, in order.

Log in to unlock

Term & fees

See the term timeline — pendency span, in-force span, the maintenance fees paid and both computed expiry dates.

Log in to unlock

Validity challenges

See the validity challenges on record — reexaminations, IPRs and PGRs, with their institution decisions and outcomes.

Log in to unlock

Citations

See every patent this one cites and every patent that cites it back — publication, assignee, and how each one was found.

Log in to unlock